Genetic factors in colorectal cancer
Genetic factors in colorectal cancer is a research topic within Pathology and Forensic Medicine. Science Explorer counts 40k research works in it since 1950. 17.1% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the comprehensive molecular characterization, genetic testing, and hereditary syndromes related to colorectal cancer. It explores topics such as microsatellite instability, DNA mismatch repair, Lynch syndrome, adjuvant chemotherapy, and the molecular basis of polyposis syndromes. The research also delves into the implications for cancer risk assessment and management.
- Molecular Characterization
- Microsatellite Instability
- Hereditary Syndromes
- DNA Mismatch Repair
- Genetic Testing
- Lynch Syndrome
- Adjuvant Chemotherapy
- Tumor Microsatellite-Instability
- Polyposis Syndromes
- Cancer Risk
- Research works
- 40k fractional, since 1950
- In the world top 10%
- 6.9k per year above
- Top-10% rate
- 17.1% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +23% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Genetic factors in colorectal cancer research?
By volume, the United States and China publish the most (1.7k and 1k works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.7k works
- 2 China 1k works
- 3 Japan 393 works
- 4 Italy 293 works
- 5 United Kingdom 276 works
- 6 Germany 240 works
- 7 India 218 works
- 8 France 194 works
- 9 Spain 180 works
- 10 Canada 150 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Genetic factors in colorectal cancer research?
By volume in 2022–2025, The University of Texas MD Anderson Cancer Center publishes the most Genetic factors in colorectal cancer research, followed by Memorial Sloan Kettering Cancer Center and Chinese Academy of Medical Sciences & Peking Union Medical College.
By volume, 2022–2025
- 1 The University of Texas MD Anderson Cancer CenterUnited States 55 works
- 2 Memorial Sloan Kettering Cancer CenterUnited States 47 works
- 3 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 28 works
- 4 Sun Yat-sen UniversityChina 27 works
- 5 Cleveland ClinicUnited States 26 works
- 6 University of North Carolina at Chapel HillUnited States 24 works
- 7 Mayo Clinic in ArizonaUnited States 23 works
- 8 Harvard UniversityUnited States 21 works
- 9 Istituti di Ricovero e Cura a Carattere ScientificoItaly 21 works
- 10 Peking UniversityChina 17 works
Who are the leading researchers in Genetic factors in colorectal cancer?
The most-cited researchers publishing on Genetic factors in colorectal cancer include Stacey Gabriel and Bert Vogelstein.
- 1 Stacey Gabriel United States 7.8k citations
- 2 Bert Vogelstein United States 7.1k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Genetic factors in colorectal cancer research done?
The largest centres of Genetic factors in colorectal cancer research in 2022–2025 are Beijing (China), New York (United States), Shanghai (China) and Guangzhou (China).
Largest cities, 2022–2025
Where is the best place to study Genetic factors in colorectal cancer?
Among universities, judged by research, Sun Yat-sen University, Chinese Academy of Medical Sciences & Peking Union Medical College and Cornell University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Sun Yat-sen UniversityChina | 51.6 | 20.2% | 2.7× | 27 | +182.1% |
| 2 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 51.5 | 20.0% | 4.6× | 28 | +101.8% |
| 3 | Cornell UniversityUnited States | 49.9 | 27.7% | 2.6× | 17 | +81.8% |
| 4 | University of MilanItaly | 49.7 | 28.5% | 2.0× | 8 | +228.9% |
| 5 | Karolinska InstitutetSweden | 47.7 | 22.7% | 3.9× | 11 | +70.4% |
| 6 | Heidelberg UniversityGermany | 45.8 | 24.7% | 3.8× | 12 | +31.4% |
| 7 | Peking UniversityChina | 43.9 | 19.9% | 1.7× | 17 | +166.4% |
| 8 | University of PennsylvaniaUnited States | 43.9 | 24.4% | 2.3× | 13 | +112.3% |
| 9 | University of California San DiegoUnited States | 42.0 | 31.1% | 1.7× | 9 | +38.9% |
| 10 | Harvard UniversityUnited States | 41.7 | 17.8% | 2.7× | 21 | +50.0% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Genetic factors in colorectal cancer research growing?
Output in 2018–2022 was 23% higher than in 2013–2017, peaking in 2021. The fastest-growing topics are Genetic factors in colorectal cancer.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.